Cullinan Therapeutics (NASDAQ: CGEM)
$29.35
(3.3%)
$0.95
Price as of May 7, 2024, 4:00 p.m. ET
Cullinan Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cullinan Therapeutics Company Info
Cullinan Oncology, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
News & Analysis
Featured Article
Why Shares of Cullinan Oncology Jumped This Week
The company's presentation at a conference got the attention of analysts and investors.
Jim Halley | Jun 9, 2023
Featured Article
Why Cullinan Oncology Stock Is Skyrocketing Today
The company announced encouraging clinical data for its experimental lung cancer drug.
Keith Speights | Jun 4, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.